Effects of Cornelian Cherry on Atherosclerosis and Its Risk Factors

Area of Science:

• Nutritional Science
• Cardiovascular Research
• Pharmacology

Background:

• Atherosclerosis involves microinflammation, plaque formation, and a pro-thrombotic state.
• Functional foods offer alternative management strategies for atherosclerosis and its complications.
• Cornelian cherry (Cornus mas L., CC) possesses polyphenols with potential therapeutic effects.

Purpose of the Study:

• To evaluate the efficacy of Cornelian cherry (CC) polyphenols in managing atherosclerosis.
• To investigate CC's impact on key atherosclerosis components: inflammation, lipid metabolism, and platelet function.
• To review existing clinical evidence for CC in atherosclerosis treatment.

Main Methods:

• Review of experimental and clinical studies on Cornelian cherry (CC) and its polyphenols.
• Analysis of CC's antioxidant and anti-inflammatory properties.
• Assessment of CC's effects on lipid spectrum, glycemia, insulin levels, and platelet activity.

Main Results:

• CC polyphenols demonstrated significant antioxidant and anti-inflammatory effects, reducing inflammatory markers.
• CC treatment favorably impacted lipid profiles (total cholesterol, LDL, triacylglycerols) and improved glycemic control and insulin secretion, comparable to statins and glibenclamide.
• Clinical trials confirmed CC's ability to decrease cholesterol, ameliorate inflammation, and improve insulin secretion.

Conclusions:

• Cornelian cherry (CC) polyphenols exhibit potent antioxidant, anti-inflammatory, lipid-lowering, and insulin-sensitizing properties.
• CC shows potential as an adjuvant therapy for atherosclerosis management.
• Further longitudinal studies with defined CC cultivars are needed to confirm efficacy.